Gene expression profiling, particularly the PAM50 intrinsic subtyping signature, has identified at least five categories of breast tumors: luminal A (LumA), luminal B (LumB), HER2-enriched (HER2), basal-like (basal) and claudin-low tumors3, each one with distinctive oncogenic features. This evidence concerns the gene ERBB2 and breast neoplasm.